Danaher collaborates with NVIDIA and Danaher stock costs EUR 207.80

Published on 10/28/2026 at 10:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Third-quarter revenue reached USD 6.6 billion, up 8.5 percent year over year. Danaher stock costs EUR 207.80 on October 28, 2026.

Growth and research strategy

Danaher announced its NVIDIA collaboration on October 14, 2026.
Third-quarter revenue reached USD 6.6 billion, up 8.5 percent year over year.
Danaher stock traded at EUR 207.80 at 10:31 a.m. CET at Lang & Schwarz on October 28, 2026.
Danaher's market capitalization was USD 163.2 billion as of October 27, 2026.

Danaher Corp., US2358511028, Illustration mit AI erstellt.

Danaher Corporation (ISIN US2358511028) is collaborating with NVIDIA on autonomous science, while its stock was trading at EUR 207.80 at Lang & Schwarz on October 28, 2026, at 10:31 a.m. CET. The companies announced the collaboration on October 14, 2026, with the goal of connecting artificial intelligence, laboratory instruments and experimental data.

AI moves into the laboratory

According to the Danaher Corporation release dated October 14, 2026, the initial work will focus on selected priority instruments. Danaher and NVIDIA are exploring accelerated computing, real-time inference, scientific reasoning and digital-twin technologies for laboratory workflows.

The announcement is strategically different from a routine software update because it connects physical instruments with models and real experimental evidence. Danaher said the collaboration is intended to shorten the path from an AI-generated prediction to laboratory validation, while preserving customer choice in models, standards and technology providers.

Growth gives the strategy context

Danaher's third-quarter 2026 results provide the operating backdrop. In its release dated October 21, 2026, Danaher Corporation reported revenue of USD 6.6 billion, up 8.5 percent year over year, and adjusted diluted earnings per share of USD 2.11, up 11.5 percent.

For the full year 2026, Danaher raised adjusted diluted earnings per share guidance to USD 8.57-8.62 from USD 8.45-8.60. The company also expects fourth-quarter core revenue excluding respiratory revenue to rise 4.0 to 5.0 percent year over year, a measure that shows where the new research strategy meets current operating execution.

Trading snapshot and company profile

Danaher stock was trading at EUR 207.80 at Lang & Schwarz on October 28, 2026, at 10:31 a.m. CET. The quote gives German investors a current euro reference while the company's primary listing is on the NYSE.

Danaher Corporation develops biotechnology, diagnostics and life sciences products and services. Its market capitalization was USD 163.2 billion as of October 27, 2026, according to the finance quote for Danaher Corporation.

The further course of trading is shown by the continuously updated real-time quote of Danaher stock.